Menu
Not yet recruiting NCT07687797

Partially Hydrolysed Whey Based Formula in Differentiation Between Non IgE Gastrointestinal Cow's Milk Protein Allergy and Milk Intolerance

No phase Interventional Cow Milk Protein Allergy Cow Milk Intolerance

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: partially hydrolysed whey based formula, amino acid based formula.
Who it may be relevant to
Registry conditions: Cow Milk Protein Allergy, Cow Milk Intolerance. Basic parameters: 1 months — 6 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Partially hydrolysed whey based formula in differentiation between non IgE gastrointestinal cow's milk protein allergy and milk intolerance

Interventions

  • Dietary supplement partially hydrolysed whey based formula
    partially hydrolysed whey based formula
  • Dietary supplement amino acid based formula
    classic pathway of cow milk protein intolerance

Primary outcome measures

  • determining the frequency of cow milk intolerance diagnosis among patients suspected for cow milk protein allergy [Time frame: 12 weeks]

Eligibility criteria

Inclusion criteria

  • 1-6 months of age
  • formula fed infants
  • CoMiSS score above 10
  • Repeated body mucoid stool

Exclusion criteria

  • IgE mediated disease
  • Skin allergy
  • Respiratory symptoms
  • Exclusive or mixed breast feeding

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Diagnostic

Study locations

Egypt · 1 center
  • Faculty of Medicine Ain Shams University — Cairo

Identifiers

NCT: NCT07687797 · FMASU R115/2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗